TY  - JOUR

T1  - Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors Is an Effective Treatment Strategy for
                    <i>MTAP</i>
                    -Deleted
                    <i>KRAS</i>
                    -Mutant Pancreatic Cancer

JO  - Cancer Research

UR  - https://doi.org/10.1158/0008-5472.can-25-1507

PY  - 2025/07/22

AU  - Drizyte-Miller K

AU  - Engstrom LD

AU  - Klomp JA

AU  - Stalnecker CA

AU  - Stamey AG

AU  - Taylor KE

AU  - Roach MK

AU  - Robb R

AU  - Waters LM

AU  - Calinisan A

AU  - Degan S et al

ED  - 

DO  - DOI: 10.1158/0008-5472.can-25-1507

PB  - American Association for Cancer Research (AACR)

VL  - 85

IS  - 18

SP  - 3540

EP  - 3557

Y2  - 2026/03/17

ER  -